Alimera Sciences Limited has received pricing and reimbursement approval for Iluvien from Comité Economique des Produits de Santé in France, Alimera Sciences announced in a press release.
The sustained-release fluocinolone acetonide intravitreal implant is indicated in the European Union to treat vision impairment associated with chronic diabetic macular edema that is insufficiently responsive to available therapies.
“France is a very strong intraocular steroid market, and we believe the availability of an innovative product to uniquely treat the disease consistently every
Uncategorized